Healthcare
Carlye and TPG get regulatory approval to buy Healthscope for $2.5 billion
Global private equity giants the Carlyle Group and TPG Capital have received a green light from Australia's Foreign Investment Review Board to acquire the country's second-largest hospital operator, Healthscope.
Actis and Sequoia look to divest from FMCG firm Paras Pharmaceuticals
PE firms Actis Capital and Sequoia Capital are reportedly set to sell their 70% stake in Indian FMCG firm Paras Pharmaceuticals for as much as $800 million.
Indian pharma firm seeks PE investments
Pharmaceutical firm Zenox Lifesciences Limited looks to raise INR6 crore ($1.3 million) in private equity investments - funding allocated to business expansion measures such as acquisitions.
GIC exits complete holdings in China's Ruinian
GIC Special Investments, the Singapore state-owned private equity investment unit, is understood to have sold its complete remaining stake in Ruinian International Co., Ltd., a manufacturer of health-related products in China.
GBS Venture, CM Capital invest in Pathway Therapeutics
New Zealand pharmaceuticals developer Pathway Therapeutics has sparked a private equity round of Series A Funding following its announcement that it is near to marketing a new breast cancer drug.
Sequoia India divests 16% stake in Dr. Lal PathLabs to TA Associates
VC firm Sequoia Capital India has reportedly agreed to sell half of its stake in in Indian diagnostics specialist Dr. Lal PathLabs to US-based PE firm TA Associates, leaving both TA Associates and five-year investor Sequoia with 16% stakes apiece in the...
ClinTec gets $12.5 million from Elephant Capital
London-listed PE firm Elephant Capital has infused INR58 crore ($12.5 million) in Indian clinical research group ClinTec International, taking a significant 28.8% minority stake.
Kalpathi Investments takes stake in Primex Healthcare
Kalpathi Investments has reportedly taken a 45% stake in diagnostic-services corporation Primex Healthcare through a round of venture funding for an undisclosed price, which is to be used to expand its operations across the Tamil Nadu region in the next...
Sequoia may exit Dr Lal PathLabs to TA Associates
Leading VC firm Sequoia Capital appears to be in advance talks to offload half of its stake in Dr Lal PathLabs, India’s largest diagnostics and pathology services chain, to US-based private equity firm TA Associates.
TA Associates may take part of Carlyle Group's stake in Claris Lifesciences - reports
American PE firm TA Associates is reportedly in talks with Indian sterile-injectables pharmaceutical company Claris Lifesciences to buy part of the Carlyle Group’s minority stake in the company.
VC-backed REVA lists in Oz
Venture capital-backed REVA Medical, a San Diego-based innovative medical device company, has raised $63 million from its initial public offering on the Australian Stock Exchange.
China Kanghui sees NYSE IPO rise
VC-backed PRC orthopedic implants manufacturer China Kanghui Holdings saw its shares rise some 3.8% from $10.25 to $10.64 on its NYSE debut, the middle of its planned pricing range, raising some $68.4 million.
ICICI considers Bharat Biotech exit - reports
ICICI Venture is reportedly looking to exit its 11% stake in Bharat Biotech through various options, including a secondary transaction or a sellout, as the firm aims to divest from many of its healthcare commitments.
Buchang Pharma gets $5 million from Navi Capital
Navi Capital reportedly invested $5 million in Shandong Buchang Pharmaceutical Co., Ltd. as part of a capital-raising process that included both foreign and domestic investors.
Maneesh Pharmaceuticals nears deal with PE firms
Mumbai-based Maneesh Pharmaceuticals is finalizing talks with private equity firms in an effort to raise INR100 crore ($21.7 million) to INR125 crore ($27.1 million), according to reports.
Japan's INCJ launching new VC funds
Innovation Network Corporation of Japan (INCJ), the government-owned fund, plans to launch intellectual property venture funds with special focuses including biotech, slating the end of this year.
Tano Capital exits Shilpa Medicare with 4.5x IRR
In its second exit this year, Indian private equity firm Tano Capital has sold its stake in pharmaceuticals manufacturer Shilpa Medicare Ltd, reportedly earning 4.5x return on its initial $2 million investment.
India's Apollo Hospitals seeks private equity investment
Apollo Hospitals is looking to garner additional funding from private equity investors to the tune of INR3,000 crore in an effort to expand its reach in India, with the company’s Chairman suggesting that a partnership with Malaysian sovereign wealth fund...
WuXi Pharma sees no exit via Charles River
VC-invested PRC pharmaceutical major WuXi PharmaTech saw its $1.6 billion sale to US peer Charles River Laboratories fail over opposition from major shareholders in Massachusetts-based Charles River, including Neuberger Berman and hedge fund Jana Partners....
WuXi Pharma exit to Charles River nixed
VC-invested PRC pharmaceutical major WuXi PharmaTech has seen its $1.6 billion sale to US peer Charles River Laboratories fail over opposition from major shareholders in Massachusetts-based Charles River, including Neuberger Berman and hedge fund Jana...
VC-backed China Kanghui seeks $75 million IPO on NYSE
VC-funded China Kanghui Holdings, a manufacturer of orthopedic implants, has filed for a $75 million IPO on the New York Stock Exchange, with investors including IDG Capital, Accel Partners, TDF Capital, CDH Ventures and VivoVentures.
ICICI Venture may offload stake in I-Ven Medicare
ICICI Venture is reportedly set to exit a large portion of its healthcare arm I-Ven Medicare India Pvt. Ltd. – which is further a component of its India Advantage Fund Series 2 - and is said to be in talks with Mumbai-based PE firm India Value Fund Advisors...
Khazanah wins Parkway
Malaysian SWF Khazanah Nasional has reportedly won the battle with Fortis Healthcare for control of Singapore hospital asset Parkway Holdings, after the latter opted to sell its entire 25.37% stake to Khazanah, as the SWF launched a $2.56 billion general...
CCBI Healthcare Fund invests Shanghai Kindly
CCBI Healthcare Fund, a fund managed by China Construction Bank International (CCBI), has invested an undisclosed sum in Shanghai Kindly Enterprise Development Group (KDL), a producer and developer of disposable medical devices.